This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Biotech immunology company BioXell SPA (spun off from Roche in March 2002) has grossed €17mm ($19.9mm) in its Series B financing. NIB Capital Private led the round and was joined by existing investors MPM Capital, Index Ventures, and Life Sciences Partners, plus new investor Investimenti Piccole.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?